StockData
Phibro Animal Health Corp logo

Phibro Animal Health Corp (PAHC) stock

PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 22/3046% below fair value
$34.92−0.10 (-0.29%)

Close on Nov 17, 2026Market cap $1.42BP/E 14.4Yield 1.37%

Phibro Animal Health total assets

Total assets on the balance sheet at the end of each period.

Phibro Animal Health's total assets was $1.50B at Jun 30, 2026. For fiscal 2026 it was $1.50B, up 10.3% from the year before. Over ten years it grew 9.5% a year on average. The highest annual figure on record is $1.50B in fiscal 2026.

Annual total assets

PeriodPeriod endValueChange
FY2026Jun 30, 2026$1.50B+10.3%
FY2025Jun 30, 2025$1.36B+38.6%
FY2024Jun 30, 2024$982.18M+1.1%
FY2023Jun 30, 2023$971.40M+4.3%
FY2022Jun 30, 2022$931.70M+10.7%
FY2021Jun 30, 2021$841.33M+7.3%
FY2020Jun 30, 2020$784.10M+7.9%
FY2019Jun 30, 2019$726.67M+8.2%
FY2018Jun 30, 2018$671.68M+7.7%
FY2017Jun 30, 2017$623.40M+2.6%
FY2016Jun 30, 2016$607.84M+23.2%
FY2015Jun 30, 2015$493.32M+4.4%
FY2014Jun 30, 2014$472.32M-0.4%
FY2013Jun 30, 2013$474.14M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$1.50B+10.3%
Q3 FY2026CQ1 2026Mar 31, 2026$1.45B+9.7%
Q2 FY2026CQ4 2025Dec 31, 2025$1.41B+9.3%
Q1 FY2026CQ3 2025Sep 30, 2025$1.39B+43.4%
Q4 FY2025CQ2 2025Jun 30, 2025$1.36B+38.6%
Q3 FY2025CQ1 2025Mar 31, 2025$1.32B+34.5%
Q2 FY2025CQ4 2024Dec 31, 2024$1.29B+32.2%
Q1 FY2025CQ3 2024Sep 30, 2024$966.29M+0.2%
Q4 FY2024CQ2 2024Jun 30, 2024$982.18M+1.1%
Q3 FY2024CQ1 2024Mar 31, 2024$979.04M+1.4%
Q2 FY2024CQ4 2023Dec 31, 2023$972.71M+1.1%
Q1 FY2024CQ3 2023Sep 30, 2023$964.52M+1.7%
Q4 FY2023CQ2 2023Jun 30, 2023$971.40M+4.3%
Q3 FY2023CQ1 2023Mar 31, 2023$965.43M+5.4%
Q2 FY2023CQ4 2022Dec 31, 2022$961.83M+13.3%
Q1 FY2023CQ3 2022Sep 30, 2022$948.38M+13.4%
Q4 FY2022CQ2 2022Jun 30, 2022$931.70M+10.7%
Q3 FY2022CQ1 2022Mar 31, 2022$916.18M+13.8%
Q2 FY2022CQ4 2021Dec 31, 2021$848.96M+5.6%
Q1 FY2022CQ3 2021Sep 30, 2021$836.04M+5.9%
Q4 FY2021CQ2 2021Jun 30, 2021$841.33M+7.3%
Q3 FY2021CQ1 2021Mar 31, 2021$805.02M+3.7%
Q2 FY2021CQ4 2020Dec 31, 2020$803.65M+1.9%
Q1 FY2021CQ3 2020Sep 30, 2020$789.55M-0.7%
Q4 FY2020CQ2 2020Jun 30, 2020$784.10M+7.9%
Q3 FY2020CQ1 2020Mar 31, 2020$776.05M+9.9%
Q2 FY2020CQ4 2019Dec 31, 2019$788.32M+13.1%
Q1 FY2020CQ3 2019Sep 30, 2019$795.24M+17.2%
Q4 FY2019CQ2 2019Jun 30, 2019$726.67M+8.2%
Q3 FY2019CQ1 2019Mar 31, 2019$706.42M+5.3%
Q2 FY2019CQ4 2018Dec 31, 2018$697.29M+5.2%
Q1 FY2019CQ3 2018Sep 30, 2018$678.48M+1.1%
Q4 FY2018CQ2 2018Jun 30, 2018$671.68M+7.7%
Q3 FY2018CQ1 2018Mar 31, 2018$670.84M+11.4%
Q2 FY2018CQ4 2017Dec 31, 2017$663.13M+12.0%
Q1 FY2018CQ3 2017Sep 30, 2017$671.11M+12.2%
Q4 FY2017CQ2 2017Jun 30, 2017$623.40M–
Q3 FY2017CQ1 2017Mar 31, 2017$602.28M–
Q2 FY2017CQ4 2016Dec 31, 2016$592.29M–
Q1 FY2017CQ3 2016Sep 30, 2016$598.08M–

More Phibro Animal Health figures

See a number that looks wrong?